StockSelector.com
  Research, Select, & Monitor Thursday, April 02, 2020 1:11:14 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Corbus Pharmaceuticals Holdings, Inc.$4.79($.45)(8.59%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Corbus Pharmaceuticals Holdings, Inc. has an overall rank of 7323 out of 7367 stocks based on 6 positive rankings and 10 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $12.00 for Corbus Pharmaceuticals Holdings using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Corbus Pharmaceuticals Holdings is ranked 285.
90 Day Gain
Corbus Pharmaceuticals Holdings rank is 332
10 Day Gain
Corbus Pharmaceuticals Holdings rank is 597
Low Put/Call
Corbus Pharmaceuticals Holdings has a low Put/Call ratio of 0.26 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Corbus Pharmaceuticals Holdings is ranked 617.
Highest Cash Growth
Corbus Pharmaceuticals Holdings rank is 733
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Corbus Pharmaceuticals Holdings is ranked 4552.
Negative Rankings
Negative Stoch Cross
Corbus Pharmaceuticals Holdings rank is 16
Negative ROE
Corbus Pharmaceuticals Holdings rank is 16
Price-to-Book
Corbus Pharmaceuticals Holdings rank is 38
Negative Revenue Estimate
Corbus Pharmaceuticals Holdings rank is 86
Negative ROA
Corbus Pharmaceuticals Holdings rank is 99
Negative Net Margin
Corbus Pharmaceuticals Holdings rank is 311
Price-to-Sales
Corbus Pharmaceuticals Holdings rank is 392
Debt-to-Equity
Corbus Pharmaceuticals Holdings rank is 524
Down EPS Surprise
Corbus Pharmaceuticals Holdings missed the consensus earnings estimate when it last reported quarterly earnings.
High vPut/Call
Corbus Pharmaceuticals Holdings has a high Put/Call ratio of 1.29 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Corbus Pharmaceuticals Holdings is ranked 1413.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.